Statement Of Cash Flows [Abstract]

Carl Zeiss Meditec AG - Filing #6525304

Concept	As at 2023-09-30	2022-10-01 to 2023-09-30	2021-10-01 to 2022-09-30	As at 2022-09-30	As at 2021-09-30
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	—	3,951 EUR	1,520 EUR	—	—
Income taxes paid (refund), classified as operating activities	—	107,106 EUR	120,444 EUR	—	—
Cash flows from (used in) operating activities	—	250,861 EUR	188,199 EUR	—	—
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities	—	10,664 EUR	61,290 EUR	—	—
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities	—	2,423 EUR	0 EUR	—	—
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities	—	21,594 EUR	5,851 EUR	—	—
Purchase of property, plant and equipment, classified as investing activities	—	65,651 EUR	42,804 EUR	—	—
Purchase of intangible assets, classified as investing activities	—	48,210 EUR	39,167 EUR	—	—
Cash flows from (used in) investing activities	—	110,980 EUR	92,886 EUR	—	—
Cash flows from (used in) financing activities [abstract]
Repayments of borrowings, classified as financing activities	—	0 EUR	1,456 EUR	—	—
Payments of lease liabilities, classified as financing activities	—	22,990 EUR	19,904 EUR	—	—
Cash flows from (used in) financing activities	—	135,094 EUR	94,244 EUR	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	1,915 EUR	779,000 EUR	—	—
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes	—	2,872 EUR	290,000 EUR	—	—
Cash and cash equivalents	10,601 EUR	—	—	7,729 EUR	7,439 EUR